Wrapping up the summer and looking ahead to biotech's post Labor Day news flow with NYSE's Eric Dimise from Kendall Square
He discusses the sector's IPO activity YTD, what we might expect through the end of the year, and what types of companies have the best chances of getting an IPO done.